The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
Year: 2012
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: M Nordio, E Proietti
Institution: Sapienza University of Rome
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2148920675